MAPK3 and neoplasm: Our research confirms that DUSP2 plays a tumor suppressive role in GC and that DUSP2 binds to ERK1/2, thereby promoting its dephosphorylation and inhibiting the MAPK/ERK pathway, resulting in EMT and reduced GC invasion and even peritoneal metastasis.